Fig. 12From: Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetabenAβ40 staining images of AD mouse at 48 weeks in a CA1, b CA2, c CA3 area of hippocampus and d cortexBack to article page